These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community. McDonald S; Maguire G; Duarte N; Wang XL; Hoy W Clin Sci (Lond); 2004 Feb; 106(2):121-8. PubMed ID: 12956621 [TBL] [Abstract][Full Text] [Related]
5. The Austin Doyle Lecture, High Blood Pressure Research Council of Australia. Renal disease as a metaphor: towards a more integrated view of aboriginal health. Hoy WE Clin Exp Pharmacol Physiol; 1998 Dec; 25(12):1038-42. PubMed ID: 9888003 [TBL] [Abstract][Full Text] [Related]
7. Cardiac care for Indigenous Australians: practical considerations from a clinical perspective. Walsh WF; Kangaharan N Med J Aust; 2017 Jul; 207(1):40-45. PubMed ID: 28659116 [TBL] [Abstract][Full Text] [Related]
8. Cardiometabolic risk and disease in Indigenous Australians: the heart of the heart study. Brown A; Carrington MJ; McGrady M; Lee G; Zeitz C; Krum H; Rowley K; Stewart S Int J Cardiol; 2014 Feb; 171(3):377-83. PubMed ID: 24388543 [TBL] [Abstract][Full Text] [Related]
9. Risk of CKD in Australian indigenous and nonindigenous children: a population-based cohort study. Haysom L; Williams R; Hodson E; Lopez-Vargas P; Roy LP; Lyle D; Craig JC Am J Kidney Dis; 2009 Feb; 53(2):229-37. PubMed ID: 18930569 [TBL] [Abstract][Full Text] [Related]
10. Associations of serum adiponectin with markers of cardio-metabolic disease risk in Indigenous Australian adults with good health, diabetes and chronic kidney disease. Hughes JT; O'Dea K; Piera K; Barzi F; Cass A; Hoy WE; MacIsaac RJ; Maple-Brown LJ Obes Res Clin Pract; 2016; 10(6):659-672. PubMed ID: 26669799 [TBL] [Abstract][Full Text] [Related]
11. Renal disease patterns in aboriginal Australians. A family-based study in a high incidence community. Van Buynder PG; Gaggin JA; Mathews JD Med J Aust; 1993 Jul; 159(2):82-7. PubMed ID: 8336607 [TBL] [Abstract][Full Text] [Related]
12. Exploring the pathways leading from disadvantage to end-stage renal disease for indigenous Australians. Cass A; Cunningham J; Snelling P; Wang Z; Hoy W Soc Sci Med; 2004 Feb; 58(4):767-85. PubMed ID: 14672592 [TBL] [Abstract][Full Text] [Related]
13. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Hoy WE; Mathews JD; McCredie DA; Pugsley DJ; Hayhurst BG; Rees M; Kile E; Walker KA; Wang Z Kidney Int; 1998 Oct; 54(4):1296-304. PubMed ID: 9767547 [TBL] [Abstract][Full Text] [Related]
14. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Menzies R; Turnour C; Chiu C; McIntyre P Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease risk in young Indigenous Australians: a snapshot of current preventive health care. Crinall B; Boyle J; Gibson-Helm M; Esler D; Larkins S; Bailie R Aust N Z J Public Health; 2017 Oct; 41(5):460-466. PubMed ID: 27372907 [TBL] [Abstract][Full Text] [Related]
16. An update on chronic kidney disease in Aboriginal Australians. Hoy WE; Mott SA; McDonald SP Clin Nephrol; 2020; 93(1):124-128. PubMed ID: 31426912 [TBL] [Abstract][Full Text] [Related]
17. Carotid artery intimal medial thickness, brachial artery flow-mediated vasodilation and cardiovascular risk factors in diabetic and non-diabetic indigenous Australians. Chan L; Shaw AG; Busfield F; Haluska B; Barnett A; Kesting J; Short L; Marczak M; Shaw JT Atherosclerosis; 2005 Jun; 180(2):319-26. PubMed ID: 15910858 [TBL] [Abstract][Full Text] [Related]
18. C-reactive protein: an independent predictor of cardiovascular disease in Aboriginal Australians. Wang Z; Hoy WE Aust N Z J Public Health; 2010 Jul; 34 Suppl 1():S25-9. PubMed ID: 20618287 [TBL] [Abstract][Full Text] [Related]
19. Albuminuria in a remote South Australian Aboriginal community: results of a community-based screening program for renal disease. Shephard MD; Allen GG; Barratt LJ; Barbara JA; Paizis K; McLeod G; Brown M; Vanajek A Rural Remote Health; 2003; 3(1):156. PubMed ID: 15877493 [TBL] [Abstract][Full Text] [Related]
20. End-stage renal disease in indigenous Australians: a disease of disadvantage. Cass A; Cunningham J; Snelling P; Wang Z; Hoy W Ethn Dis; 2002; 12(3):373-8. PubMed ID: 12148708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]